DGAP-News: Heidelberg Pharma Announces Participation at Various Conferences
Ladenburg, Germany, 17 June 2021 - Heidelberg Pharma AG (FSE: HPHA) today announced that they will present its proprietary ATAC technology at two upcoming scientific events.
- Ladenburg, Germany, 17 June 2021 - Heidelberg Pharma AG (FSE: HPHA) today announced that they will present its proprietary ATAC technology at two upcoming scientific events.
- Heidelberg Pharma AG is a biopharmaceutical company based in Ladenburg, Germany.
- Heidelberg Pharma is an oncology specialist and the first company to develop the toxin Amanitin into cancer therapies.
- Heidelberg Pharma AG is listed on the Frankfurt Stock Exchange: ISIN DE000A11QVV0 / WKN A11QVV / Symbol HPHA.